Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

ClinicalTrials.gov ID: NCT00083967

Public ClinicalTrials.gov record NCT00083967. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Masked, Placebo Controlled, Parallel Group, Multi-Center, Dose-Ranging Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Rhegmatogenous Retinal Detachment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to test if denufosol will remove the fluid build-up in the eye so that the retina can be re-attached without invasive surgery.

Study identification

NCT ID
NCT00083967
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
23 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2004 (Type not available)
Primary completion
Apr 2006 (Actual)
Completion
Apr 2006 (Actual)
Last update posted
Apr 10, 2015

2004 – 2006

United States locations

U.S. sites
33
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Retina Center, P.C. Tucson Arizona 85704 —
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 —
Retina Vitreous Associates Medical Group Los Angeles California 90017 —
Retina Consultants San Diego Poway California 92064 —
Danbury Eye Physicians & Surgeons, P.C. Danbury Connecticut 06810 —
Retina Group of Florida Fort Lauderdale Florida 33334 —
Central Florida Retina Orlando Florida 32806 —
The University of Chicago Chicago Illinois 60637 —
Illinois Retina Associates, S.C. Joliet Illinois 60435 —
Midwest Eye Institute Indianapolis Indiana 46280 —
University of Kentucky, The Kentucky Clinic Lexington Kentucky 40536 —
Maine Vitreoretinal Consultants Bangor Maine 04401 —
National Retina Institute Chevy Chase Maryland 20815 —
New England Eye Center Boston Massachusetts 02111 —
Kresge Eye Institute/Hutzel Hospital Detroit Michigan 48201 —
Retina Associates Kansas City Missouri 64111 —
Retina Associates of NJ Millburn New Jersey 07041 —
Retina Associates of NJ Teaneck New Jersey 07666 —
Retina Associates of NJ Wayne New Jersey 07470 —
NY Eye and Ear Infirmary New York New York 10003 —
Carolina Eye Associates Southern Pines North Carolina 28387 —
Retina Associates of Cleveland Beachwood Ohio 44122 —
Retina Assocites of Cleveland, Inc. Cleveland Ohio 44107 —
Cleveland Clinical Foundation Cleveland Ohio 44195 —
Retina Associates of Cleveland Lakewood Ohio 44107 —
Retina Associates of Cleveland Lorain Ohio 44052 —
Retina Associates of Cleveland Middleburg Heights Ohio 44130 —
Scheie Eye Institute Philadelphia Pennsylvania 19104 —
Austin Retina Austin Texas 78705 —
Vitreoretinal Consultants Houston Texas 77030 —
Wagner Mandell Retina Center Norfolk Virginia 23505 —
Wagner Mandell Retina Center Virginia Beach Virginia 23454 —
Medical College of Wisconsin/The Eye Institute Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00083967, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 10, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00083967 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →